Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Uterine Cancer to Oncology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Uterine Cancer to Oncology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Uterine Cancer Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Uterine Cancer 29 Apr 17, 2016: Precision Biologics, a NantWorks Company, to Present Combination Immunotherapy of a Novel Neo-Epitope Antibody Targeting Ovarian and Uterine Cancer at the AACR Annual Meeting 2016 29 Clinical Trial Profile Snapshots 30 Appendix 939 Abbreviations 939 Definitions 939 Research Methodology 940 Secondary Research 940 About GlobalData 941 Contact Us 941 Disclaimer 941 Source 942

List of Tables Uterine Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 6 Uterine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Uterine Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Uterine Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Uterine Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Uterine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Uterine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Uterine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Uterine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures Uterine Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Uterine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Uterine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Uterine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Uterine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Uterine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Uterine Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Uterine Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Uterine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Uterine Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Uterine Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Uterine Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Uterine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Uterine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Uterine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Uterine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Uterine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Uterine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Uterine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Uterine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 940

GlaxoSmithKline Plc Merck & Co., Inc. AstraZeneca Plc F. Hoffmann-La Roche Ltd. Novartis AG Sanofi Bristol-Myers Squibb Company Pfizer Inc. Eli Lilly and Company Pharma Mar, S.A.